Clinical Operations, • 9/19/25 Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Previous Optimizing CRO and Vendor Selection - Examples from the Field Next Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Solutions for Trial Design Challenges in Rare Disease Trials How To Prevent Failure in Rare Disease Trials?
Clinical Operations, • 9/19/25 Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Previous Optimizing CRO and Vendor Selection - Examples from the Field Next Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Solutions for Trial Design Challenges in Rare Disease Trials How To Prevent Failure in Rare Disease Trials?
